HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?

被引：33
|
作者：
Furukawa, Hiroshi [1 ]
Oka, Shomi
Shimada, Kota [2 ,3 ]
Tsuchiya, Naoyuki [4 ]
Tohma, Shigeto
机构：
[1] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan
[2] Sagamihara Hosp, Natl Hosp Org, Dept Rheumatol, Sagamihara, Kanagawa 2520392, Japan
[3] Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan
[4] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 01期
关键词：
STEVENS-JOHNSON-SYNDROME; HLA-B; ASSOCIATION; ABACAVIR; ALLELE;
D O I：
10.1136/annrheumdis-2012-201944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：153 / 155
页数：3
相关论文
共 50 条
  • [21] Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
    Riccardo Messina
    Giuliana Guggino
    Alida Benfante
    Nicola Scichilone
    Drugs & Aging, 2020, 37 : 11 - 18
  • [22] Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
    Messina, Riccardo
    Guggino, Giuliana
    Benfante, Alida
    Scichilone, Nicola
    DRUGS & AGING, 2020, 37 (01) : 11 - 18
  • [23] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Kur-Zalewska, J.
    Raczkiewicz, A.
    Bujakowska, O.
    Juszkiewicz, A.
    Tlustochowicz, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 913 - 914
  • [24] Does methotrexate cause interstitial lung disease in rheumatoid arthritis: What is the evidence?
    Malaviya, Anand Narayan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (06) : 713 - 716
  • [25] Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis
    Carrasco Cubero, Carmen
    Chamizo Carmonaba, Eugenio
    REUMATOLOGIA CLINICA, 2022, 18 (07): : 440 - 441
  • [26] Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis - A multicenter, case-control study
    Alarcon, GS
    Kremer, JM
    Macaluso, M
    Weinblatt, ME
    Cannon, GW
    Palmer, WR
    StClair, EW
    Sundy, JS
    Alexander, RW
    Smith, GJW
    Axiotis, CA
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) : 356 - +
  • [27] Methotrexate Might Increase Mortality from Interstitial Lung Disease in Rheumatoid Arthritis
    Toyoshima, Mikio
    Chida, Kingo
    Suda, Takafumi
    Sato, Masaki
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (09) : 1024 - 1024
  • [28] Methotrexate-induced oral mucositis in rheumatoid arthritis disease: Therapeutic strategy in a case report
    Biasotto, M. (m.biasotto@fmc.units.it), 1600, Walter de Gruyter GmbH (02):
  • [29] A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients
    Kur-Zalewska, Joanna
    Kisiel, Bartlomiej
    Kania-Pudlo, Marta
    Tlustochowicz, Malgorzata
    Chcialowski, Andrzej
    Tlustochowicz, Witold
    PLOS ONE, 2021, 16 (04):
  • [30] Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis
    Kent, PD
    Luthra, HS
    Michet, CJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (09) : 1727 - 1731
12345